| Cancer cachexia is defined by an ongoing loss of skeletal muscle mass |
17 |
| Sarcopenia associated with chemotherapy and targeted agents for cancer therapy |
14 |
| Bleeding in cancer patients and its treatment: a review |
11 |
| Implementation issues relevant to outpatient neurology palliative care |
10 |
| Lipid metabolism in cancer cachexia |
9 |
| Cannabis in palliative care: current challenges and practical recommendations |
9 |
| Improving patient outcomes through palliative care integration in other specialised health services: what we have learned so far and how can we improve? |
9 |
| Palliative care-the new essentials |
8 |
| PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer |
8 |
| A fetal diagnostic center's referral rate for perinatal palliative care |
7 |
| A hunger for hunger: a review of palliative therapies for cancer-associated anorexia |
7 |
| Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI) |
7 |
| Anti-cytokines in the treatment of cancer cachexia |
6 |
| Questionnaires measuring quality of life and satisfaction of patients and their relatives in a palliative care setting-German translation of FAMCARE-2 and the palliative care subscale of FACIT-Pal |
6 |
| The role of clinical hypnosis and self-hypnosis to relief pain and anxiety in severe chronic diseases in palliative care: a 2-year long-term follow-up of treatment in a nonrandomized clinical trial |
5 |
| Prokinetics and ghrelin for the management of cancer cachexia syndrome |
5 |
| Healthy End of Life Project (HELP): a progress report on implementing community guidance on public health palliative care initiatives in Australia |
4 |
| Compassionate Communities in Canada: it is everyone's responsibility |
4 |
| A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide |
4 |
| Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care? - a critical appraisal of recent randomized controlled trials |
4 |
| Early palliative care and the opioid crisis: ten pragmatic steps towards a more rational use of opioids |
4 |
| What are the criteria for response to cachexia treatment? |
4 |
| Perinatal bereavement and palliative care offered throughout the healthcare system |
4 |
| Economic outcomes in palliative and end-of-life care: current state of affairs |
4 |
| Starting from scratch: implementing outcome measurement in clinical practice |
4 |
| Invisible and intangible illness: a qualitative interview study of patients' experiences and understandings of conservatively managed end-stage kidney disease |
4 |
| External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs) |
4 |
| MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE(-/-) mice |
4 |
| Anxiety and psychosomatic symptoms in palliative care: from neuro-psychobiological response to stress, to symptoms' management with clinical hypnosis and meditative states |
4 |
| Advanced radiotherapy for metastatic disease-a major stride or a futile effort? |
4 |
| Palliative care for Parkinson's disease |
4 |
| Advance care planning for patients with advanced neurology diseases |
4 |
| Sexual healthcare for cancer patients receiving palliative care: a narrative review |
4 |
| STAT RT: a prospective pilot clinical trial of Scan-Plan-QA-Treat stereotactic body radiation therapy for painful osseous metastases |
3 |
| Immunotherapy and radiotherapy for metastatic cancers |
3 |
| Triggers for referral to neurology palliative care service |
3 |
| Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastases |
3 |
| Hydrogen-oxygen therapy can alleviate radiotherapy-induced hearing loss in patients with nasopharyngeal cancer |
3 |
| The effectiveness and safety of acupuncture for the treatment of myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials |
3 |
| Acupoint injection treatment for primary osteoporosis: a systematic review and meta-analysis of randomized controlled trials |
3 |
| Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation |
3 |
| Palliative care in Botswana: current state and challenges to further development |
3 |
| Radiotherapy for patients with unresected locally advanced breast cancer |
3 |
| Pediatric palliative care nursing |
3 |
| Models of non-hospice palliative care: a review |
3 |
| Combination therapy in cachexia |
3 |
| Health-related quality of life across cancer cachexia stages |
3 |
| Measuring cachexia-diagnostic criteria |
3 |
| The impact of non-medical reading on clinician burnout: a national survey of palliative care providers |
3 |
| Expression of receptor interacting protein 3 and mixed lineage kinase domain-like protein-key proteins in necroptosis is upregulated in ulcerative colitis |
3 |
